Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
4.980
+0.320 (6.87%)
At close: Dec 20, 2024, 4:00 PM
5.16
+0.18 (3.61%)
After-hours: Dec 20, 2024, 7:59 PM EST
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $24.08 million as of December 20, 2024. Its market cap has increased by 26.57% in one year.
Market Cap
24.08M
Enterprise Value
19.41M
1-Year Change
26.57%
Ranking
Category
Stock Price
$4.98
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $24.08M, a decrease of -76.74%. That is a compound annual growth rate of -30.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 24.08M | 61.68% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 23.81M |
| Longeveron | 23.74M |
| NeuroOne Medical Technologies | 23.38M |
| Alterity Therapeutics | 23.31M |
| Co-Diagnostics | 23.16M |
| Cara Therapeutics | 22.43M |
| iBio, Inc. | 22.14M |
| Allurion Technologies | 22.08M |